Parallel Advisors’s Affimed AFMD Stock Holding History

Parallel Advisors’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,500	Closed	-$33K	–	2091
2017 Q1	$33K	Buy	+1,500	New	+$33K	0.01%	771

Other funds holding AFMD

Wellington Management Group

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Nationwide Fund Advisors Columbus, Ohio $2.42B AUM 17.68% 1-Year Est. Return

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Parallel Advisors's AFMD Position: Q2 2017 in Review

Parallel Advisors sold out of Affimed (AFMD) in Q2 2017, closing a stake of 1,500 shares — an estimated $33K sold.

Parallel Advisors first reported a position in AFMD in Q1 2017 and held it in 1 quarter. The position peaked at $33K in Q1 2017. 31 funds tracked by Wall St. Rank hold AFMD as of Q2 2017.

Parallel Advisors reported no remaining Affimed position as of Q2 2017 after selling out during the quarter.
Parallel Advisors sold 1,500 Affimed shares in Q2 2017, an estimated $33K.
Parallel Advisors first reported a position in Affimed in Q1 2017 and held it in 1 quarter.
Parallel Advisors's Affimed position peaked at $33K in Q1 2017.
31 funds tracked by Wall St. Rank held Affimed as of Q2 2017.

Based on Parallel Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.